Arthur Fratamico - Mar 27, 2023 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Mar 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/29/2023, 04:22 PM
Previous filing
May 27, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Stock Option (right to buy) Award $0 +8.33K $0.00 8.33K Mar 27, 2023 Common Stock 8.33K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options scheduled to vest on the earlier of day before annual meeting of stockholders or one year anniversary.